Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00086411 · ClinicalTrials.gov registry record · Phase 2
Comparing Smoking Treatment Programs for Lighter Smokers - 1
A Phase 2 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 260
- Enrollment target
NCT00086411: Completed Phase 2 study, sponsored by University of Pennsylvania.
NCT00086411 is a Phase 2 study that has completed, run by University of Pennsylvania. The registered enrollment target is 260 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00086411, a Phase 2 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 260 participants
- Enrollment target
Study Summary
The purpose of this study was to compare two different types of Food and Drug Administration (FDA) approved smoking cessation medications (nicotine patch or bupropion) used in conjunction with two levels of counseling. It was hypothesized that the higher level of counseling would have the highest rates of treatment completion and highest rates of abstinence.
Interventions
- DRUG nicotine transdermal system
- DRUG bupropion
- DRUG placebo patch
- BEHAVIORAL Medication Management
- BEHAVIORAL Mayo Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2003-09 |
| Est. Completion | 2009-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00086411
The ClinicalTrials.gov registry entry for NCT00086411 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which nicotine transdermal system is the first listed.
NCT00086411 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00086411 about?
NCT00086411 is a clinical study titled "Comparing Smoking Treatment Programs for Lighter Smokers - 1". The purpose of this study was to compare two different types of Food and Drug Administration (FDA) approved smoking cessation medications (nicotine patch or bupropion) used in conjunction with two levels of counseling. It was hypothesized that the higher level of counseling would have the highest ra...
What is the current status of trial NCT00086411?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 260 participants. The study started on 2003-09. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00086411?
The interventions under investigation include: nicotine transdermal system (DRUG), bupropion (DRUG), placebo patch (DRUG), Medication Management (BEHAVIORAL), Mayo Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00086411?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.